900. Switching to DTG/3TC Fixed-Dose Combination (FDC) Is Non-inferior to Continuing a TAF-Based Regimen (TBR) in Maintaining Virologic Suppression Through 144 Weeks (TANGO Study)

BACKGROUND: DTG/3TC is a complete 2-drug regimen (2DR) for the treatment of HIV-1 infection. Non-inferior virologic efficacy has been proven over 3 years in treatment-naive people living with HIV (PLWH) and 2 years in a stable switch setting. METHODS: TANGO, a randomized, open-label, non-inferiority...

Descripción completa

Detalles Bibliográficos
Autores principales: Osiyemi, Olayemi, Ajana, Faïza, Bisshop, Fiona, De Wit, Stéphane, Portilla, Joaquín, Routy, Jean-Pierre, Wyen, Christoph, Ait-Khaled, Mounir, Pappa, Keith, Wang, Ruolan, Leone, Peter, Wright, Jonathan, Wynne, Brian, van Wyk, Jean A, Aboud, Michael, Smith, Kimberly
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644729/
http://dx.doi.org/10.1093/ofid/ofab466.1095

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644729/
http://dx.doi.org/10.1093/ofid/ofab466.1095

Ejemplares similares